13.07.2015 Views

Guidelines for Complications of Cancer Treatment Vol VIII Part B

Guidelines for Complications of Cancer Treatment Vol VIII Part B

Guidelines for Complications of Cancer Treatment Vol VIII Part B

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

such as concomitant use <strong>of</strong> prophylactic antibiotics. Otherstudies did not find a statistically significant difference betweenthe two operating room environments 32 . Currently, the role <strong>of</strong>laminar airflow in the prophylaxis is controversial ifprophylactic antibiotics are used.Control measures <strong>for</strong> methicillin-resistantStaphylococcus aureusMRSA has become an important cause <strong>of</strong> surgical woundinfections, with an increased incidence within both hospitalsand the community. Monthly bacterial colonization rates varybetween 6.6% and 23%, with an MRSA infection rate <strong>of</strong>3% 33,34 . This are likely to be higher in India. Simple measures,such as meticulous hand hygiene, patient screening, carefulsurveillance <strong>of</strong> infections, and prompt implementation <strong>of</strong>isolation policies, are essential components <strong>of</strong> control 35-37 .Preoperative nasal carriage <strong>of</strong> S. aureus represents a risk factor<strong>for</strong> surgical site infections 7 . Up to 5.3% <strong>of</strong> orthopedic patientsare colonized with methicillin-resistant strains <strong>of</strong> staphylococcion hospital admission 38 . Current guidelines advocate screening<strong>for</strong> MRSA carriage in patients at high risk (ie, patients whohave spent more than 5 days in acute or long-term carecenters) 39 .Intranasal mupirocin has been evaluated in the prevention <strong>of</strong>surgical site infections. Although intranasal mupirocin reducednasal carriage <strong>of</strong> S aureus, several studies failed to demonstratea significant reduction in surgical site infection rates 40-42 . Inone study, the rate <strong>of</strong> endogenous S aureus infections was fivetimes lower in the mupirocin group than in placebo group(0.3% and 1.7%, respectively), although this difference wasnot statistically significant 40 . Other studies have shown apotential benefit in reduction <strong>of</strong> surgical site infections by usingmupirocin. One study that used a historical control groupshowed a significant reduction in the surgical site infection129

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!